Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Prostate specific membrane antigen (PSMA) targeted nanoparticles for therapy of prostate cancer

Prostate specific membrane antigen (PSMA) targeted nanoparticles for therapy of prostate cancer

US Patent 10369113 · Granted Aug 6, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

PSMA targeted radiohalogenated urea-polyaminocarboxylates for cancer radiotherap2025
PSMA targeted radiohalogenated urea-polyaminocarboxylates for cancer radiotherap2025
PSMA targeted radiohalogenated urea-polyaminocarboxylates for cancer radiotherap2025
Methods and related aspects for pathology prognosis2024
Imaging and radiotherapeutics agents targeting fibroblast-activation protein-α (2024
PSMA-based molecular-genetic reporter system2024
PSMA-binding agents and uses thereof2024
PSMA-binding agents and uses thereof2024
PSMA targeted fluorescent agents for image guided surgery2024
PSMA targeted fluorescent agents for image guided surgery2024
PSMA targeted fluorescent agents for image guided surgery2024
Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane c2024